anxiety and depression are very common in population and occur in a wide range of clinical states and is very common in epileptic patients. many recent epidemiological studies have found a high prevalence of depression and anxiety in epileptic patients. these studies found that epileptic patients suffered from depression and anxiety than those without epilepsy. the prevalence of depression or a...

Background: Epilepsy is the second common neurologic disorder. Although many antiepileptic drugs have been formulated to control the seizures, but not all seizures have been controlled by them. Uncontrolled epilepsy can actually reduce the patients’ quality of life. Objectives: Identifying the proportion of adult intractable epilepsy among epileptic patients in an area in the North East o...

Introduction: Epilepsy is a complex pervasive neurobehavioral and social condition accompanied by a wide range of comorbid conditions that can adversely affect the quality of life of patients. Sleep complaints are common among patients with epilepsy. The aim of this study was to assess the prevalence of subjective sleep disturbances and its effects on sleep quality in epileptic patients.  Me...

Considering the burden of epilepsy on society, investigation of the health-related quality of life (HRQoL) is essential for the better future targeting, optimization of current interventions and managing strategies for epilepsy. Nineteen HRQoL were investigated in this review. Increases in seizure incidence, level of depression and seizure severity were significantly related to reduced HRQoL. T...

abstract background: better control of blood sugar and reduction of diabetes complications through insulin therapy could convince people to choose this method. however, patients might refuse insulin therapy due to its painful injection, limitations in daily activities, and hypoglycemia. thus, insulin therapy could have both positive and negative effects on patients’ quality of life (qol). there...

epilepsy is one of the most common neurologic diseases around the world and more significantly in iran (0.4-1 % worldwide and 5% in iran). almost one-third of these patients suffer from treatment-resistant epilepsy, which reduces their quality of life by recurring epileptic onsets. there are different approaches for the treatment of both treatment-resistant and treatment-nonresistant epilepsy, ...